Trinity Biotech (TRIB) Shares Outstanding (Diluted Average) (2021 - 2022)
Trinity Biotech's (TRIB) quarterly Shares Outstanding (Diluted Average) came in at $190.0 in Q2 2022, up 375.0% year-on-year from $40.0 in Q2 2021, and up 375.0% quarter-over-quarter from $40.0 in Q2 2021.
Trinity Biotech (TRIB) Shares Outstanding (Diluted Average) (2021 - 2022) Analysis & Trends
Trinity Biotech has disclosed Shares Outstanding (Diluted Average) across 2 years of filings, most recently posting $190.0 for Q2 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Diluted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 1.75 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 386.50 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 1.29 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 1.50 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 580.70 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 393.60 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 457.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | - |
| 10 | Trinity Biotech | 23,520.00 | -5.11 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | 190.00 |
| Jun 30, 2021 | 40.00 |